PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Zoledronic acid
Presentation Product Chemical substance Chapter Items dispensed
Zoledronic acid 4mg/5ml solution for infusion vials
0606020V0AAABAB
Zoledronic acid Zoledronic acid Endocrine System 6
Zoledronic acid 4mg/100ml solution for infusion bottles
0606020V0AAADAD
Zoledronic acid Zoledronic acid Endocrine System 4
Zoledronic acid 4mg/100ml solution for infusion vials
0606020V0AAAEAE
Zoledronic acid Zoledronic acid Endocrine System 3
Zoledronic acid 5mg/100ml solution for infusion bottles
0606020V0AAACAC
Zoledronic acid Zoledronic acid Endocrine System 3
Zoledronic acid 5mg/100ml solution for infusion vials
0606020V0AAAFAF
Zoledronic acid Zoledronic acid Endocrine System 1
Aclasta 5mg/100ml solution for infusion bottles
0606020V0BCAAAC
Aclasta Zoledronic acid Endocrine System No data available
Zerlinda 4mg/100ml infusion bags
0606020V0BDAAAD
Zerlinda Zoledronic acid Endocrine System No data available
Zoledronic acid 4mg inf vials
0606020V0AAAAAA
Zoledronic acid Zoledronic acid Endocrine System No data available
Zoledronic acid 5mg/100ml infusion bags
0606020V0AAAGAG
Zoledronic acid Zoledronic acid Endocrine System No data available
Zometa 4mg inf vials
0606020V0BBAAAA
Zometa Zoledronic acid Endocrine System No data available
Zometa 4mg/100ml solution for infusion bottles
0606020V0BBACAD
Zometa Zoledronic acid Endocrine System No data available
Zometa 4mg/5ml solution for infusion vials
0606020V0BBABAB
Zometa Zoledronic acid Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.